Background: Esophagostomy feeding tubes (E-tubes) are an essential tool for management of hyporexic patients' acute and chronic nutritional requirements.
| INTRODUCTION
Esophagostomy feeding tubes (E-tubes) are an essential tool for management of hyporexic patients' acute and chronic nutritional requirements, as well as a method for provision of medications and supplemental free water in patients intolerant of IV fluid support. Despite their common use, limited information is available regarding E-tube complications, especially in the recent veterinary literature. Previous studies have reported complication rates ranging from 13 to 71%, with major complications being far less common. [1] [2] [3] The most common complications reported with E-tube placement included vomiting, patient removal of the tube, mechanical difficulties (eg, tube obstruction, tube nozzle dislodgement), and vomiting of the tube. Peristomal inflammation, infection and abscess formation, and necrotic tissue were noted to be less common (13%-25%).
In most cases, infections were associated with poor at-home stoma care and were easily manageable. [1] [2] [3] In a retrospective study of cats undergoing E-tube placement, 19/52 (36.5%) cats experienced a complication after the procedure. 3 Of these 19 cases, 13 were characterized as mild and did not require any adjustments to treatment. Of the more severe complications, 4 cats developed abscesses that required treatment, with 3 of these cats treated successfully with modifications to home care, cleansing in-clinic, and antibiotics. One of the cats' abscesses was characterized as more severe and required hospitalization to manage the infection and salvage the tube.
Another retrospective study compared complications associated with esophagostomy vs percutaneous endoscopic gastrostomy (PEG) feeding tubes and found a complication rate of 71.7% in cats with Etubes, with 39% of these being classified as minor and 61% moderate in severity. 2 No statistical difference was found between PEG tubes and E-tubes with regard to complications.
More recent veterinary literature has focused on procedural descriptions 4,5 and novel uses of E-tubes, such as indwelling esophageal balloon dilatation for esophageal strictures 6 and continuous suctioning for longterm management of megaesophagus. 7 However, limited information regarding complications associated with E-tubes has been published in the past decade. [1] [2] [3] The objectives of our retrospective study were to provide an updated descriptive account of E-tube complications and to investigate novel aspects of E-tube management, including time to institution of feeding and bacterial isolates causing E-tube site infections.
| MATERIALS AND METHODS

Medical records of dogs and cats that had E-tubes placed between
March 2014 and March 2017 at the investigators' tertiary referral center were retrospectively reviewed. Dogs and cats were included if they had an E-tube placed and maintained for at least 24 hours.
For dogs and cats that met the initial inclusion criteria, medical records were reviewed for patient and E-tube placement data, as well as complications documented while in hospital and during follow-up visits. Patient data included signalment, clinicopathologic abnormalities, primary disease processes, and comorbidities (including immunosuppressive conditions). Placement data included tube size, mode of confirmation, procedural complications, anesthesia data, and concurrent procedures. Records were reviewed for daily observations and changes in management of E-tube sites (if applicable). If aerobic culture and sensitivity were performed, the results were recorded.
Cultures were obtained using skin swabs and placed in a sterile culture tube in all cases. Follow-up visits, surgical reports, and anesthetic records also were reviewed. Primary care veterinarians were contacted for follow-up data after discharge. Reason for removal, infection outcome, duration of time the tube was in place, and euthanasia (if applicable) were recorded. 
| Statistical analysis
| Sample population and clinical data
During the 3-year study period, 250 patients met the initial criteria.
Fifteen were excluded because of incomplete records. An additional 10 were removed from analysis because the E-tube was in place for <24 hours, resulting in 225 cases for inclusion in the final analysis.
Of these 225 cases, 102 were dogs and 123 were cats.
The median age of cats was 8 years (range, 1-6 years) and median weight was 4.4 kg (range, 1.75-10.9 kg). One hundred twelve cats had tube size reported, all of which had a 14-French (Fr) E-tube placed. The primary disease process was recorded for all cats, with renal disease being most common (52 total, with 11 receiving intermittent hemodialysis). The other patients were being managed for hepatic disease (23), gastrointestinal disease (14), pancreatitis (10), respiratory disease (7), trauma (6), orofacial disease (5), infectious disease (2), diabetes mellitus (1), and neurologic disease (1) . In terms of concurrent immunosuppressive conditions, in addition to the 1 patient with diabetes mellitus, 12 cats were diagnosed with neoplasia. Nine patients were receiving systemic immunosuppressive drugs, including corticosteroids and chemotherapeutic agents. Ninety-three cats had received PO antibiotics during or after hospitalization. Twenty-two patients were hypoalbuminemic (1.4-2.4 g/dL), 31 had a leukocytosis (16 790-39 680/ μL), 2 were leukopenic (1000-5060/μL), and 7 had a left shift noted on CBC. 
Eighty
| Complications
Of the 225 cases, 100 (44.4%) experienced a complication, with a similar complication rate among dogs (44 total, 43.1%) and cats (56 total, 45.5%). Complications were recorded during initial hospitalization as well as during follow-up visits. Six cats (4.8%) and 4 dogs (3.9%) had erythema noted around the stoma in hospital, whereas 14 cats (11.3%) and 13 dogs (12.7%) were noted to have erythema at followup. Nine cats (7.3%) and 14 dogs (13.7%) were noted to have inflammation around the stoma in hospital and 19 cats (15.4%) and 14 dogs (13.7%) at follow-up. Fifteen cats (12.2%) and 12 dogs (11.7%) had active mucoid, mucopurulent, or purulent discharge around the stoma in hospital and 28 cats (22.7%) and 20 dogs (19.6%) had discharge noted at follow-up.
Seventeen cats (13.8%) and 10 dogs (9.8%) had loose sutures noted at follow-up, requiring resuturing of the site. Two cats (1.6%) and 2 dogs (1.9%) were evaluated for vomiting of the tube.
Two cats (1.6%) and 5 dogs (4.9%) required tube readjustment based on radiographs because of tube migration, and 7 cats (5.6%) and 7 dogs (6.8%) required replacement with a new tube because of dislodgement. Two cats (1.6%) and 1 dog (0.9%) were reported to have discomfort on examination, and 1 cat (0.8%) presented for an obstructed tube requiring removal.
One cat (0.8%) and 7 dogs (6.8%) had evidence of food coming through the stoma. Dogs were significantly more likely to develop this complication, compared to cats (P = .02). Three of the dogs (42.8%) with this complication were dialysis patients. Four patients (including the 3 dialysis patients) were >20 kg. Tube size was not recorded in these specific cases. One of these patients was under anesthesia for 450 minutes, which was the longest anesthetic event for all dogs. Two of these dogs were hypoalbuminemic (1.7 g/dL and 2.3 g/dL), both of which also had evidence of leukocytosis (19 608/μL without a left shift and 48 960/μL with a concurrent left shift). Five of these patients were receiving antimicrobials; none were receiving immunosuppressive drugs.
Twenty-two cats (17.8%) and 14 dogs (13.7%) developed clinical signs consistent with infection, with 5 cats (4%) and 4 dogs (3.9%) developing signs during hospitalization and 17 cats (13.8%) and 10 dogs (9.8%) having signs noted at follow-up. Presumed infections were noted to occur at a median of 7 days after tube placement in both cats and dogs (range, 2-195 days). Six cats (4.8%) and 1 dog (0.9%) developed necrotic skin around the stoma that was noted at follow-up visits, ranging from 2 to 22 days after initial placement. Esophagostomy tubes were kept in place for a median of 19 days in both cats and dogs (range, 1-283 days for dogs, 2-609 days for cats). 
| Surgical intervention and outcomes
| Bacterial culture results
Twenty-five patients with signs consistent with infection or discharge at the stoma had aerobic cultures performed. Three patients had a negative culture, but all 3 were on systemic antimicrobial treatment at the time the culture was collected. The results of the positive cultures are presented in Table 1 . Fifteen (68%) of these culture results were polymicrobial and 10 (45%) had evidence of either methicillin resistance or multidrug resistant patterns.
| Prognostic factors and associations
No statistically significant associations were found between any variables of interest (patient weight, age, hypoalbuminemia, leukocytosis, leukopenia, use of antimicrobial or immunosuppressive drugs, concurrent disease processes, time to initiation of feeding, duration tube was in place, size of tube, and method of confirmation of placement) and risk of developing an E-tube complication or infection in the cats and dogs in this study (P ≥ .09).
| DISCUSSION
Our study provides an updated descriptive review of complications associated with E-tube placement in a large population of dogs and cats at a tertiary referral center. The overall incidence of complications was comparable to that of previous studies, 1-3 with the majority of complications being minor and easily manageable.
However, 16% of patients developed infection at the site and 3 patients were euthanized because of tube-related complications.
Although most of the reported complications in our study have been noted previously, to our knowledge, regurgitation of food through the stoma has not been previously reported. Eight patients had evidence of food coming through the stoma, with dogs being more likely to experience this complication. The E-tubes were removed in 2 patients because of this complication; 1 patient was euthanized because of this recurrent complication and the need for repeated surgical intervention.
One limitation of the medical records system at our institution is that 30 Fr E-tubes have an ambiguous charge code that did not permit notation of patients in which this size of E-tube was utilized. Of the 8 patients that regurgitated food through their stoma, 4 patients did not have tube size recorded because of this fact. It is possible that Staphylococcus pseudintermedius infections that have found Staphylococcal spp. to be the most common organism cultured. 8, 9 This finding may indicate that the agents responsible for E-tube site infections are enteric in origin, rather than skin commensals. Many (45%) of the bacterial organisms isolated in our study were methicillin resistant or had multidrug The major limitation of our study was its retrospective nature.
Although patients were excluded if their medical records were incomplete, the details recorded for a given patient's tube site assessment were variable and clinician-or nurse-dependent. It is possible that mild complications such as slight erythema or inflammation at the site may have been overlooked. Not all E-tube sites were thoroughly evaluated daily, and it is possible that some observations were not consistently recorded. Follow-up was limited in some cases, and although primary care veterinarians were contacted for additional follow-up data, mild complications again may have been overlooked. Major complications such as those that required surgical debridement were more likely to be recorded in detail and less likely to be disregarded, therefore providing a more accurate representation of major complication rate.
Despite the relatively large case numbers included in our study, we were unable to identify any statistically significant risk factors or draw any conclusions about which patients, if any, might be predisposed to E-tube complications. It is possible that our study was underpowered to detect such differences, but it also may indicate that development of complications is a result of at-home management factors, rather than patient-specific or hospital-related factors. Based on our findings, there is no evidence that patients with hypoalbuminemia, those on immunosuppressive drugs, and those receiving hemodialysis treatment, are more at risk for infection.
At the same time, our results suggest that even the most stable patient without complicating factors is at a similar risk for developing a complication and, as such, thorough follow-up and monitoring remain necessary.
Esophagostomy tubes are a beneficial tool to provide nutrition to hyporexic patients, but they are not without risk. Severe complications were rare in our study, which is in accordance with earlier studies. However, despite their limited occurrence, when these severe 
